As mentioned earlier, numerous studies demonstrated alterations in IL-6 and TNF-α levels in patients with depression [110,111], bipolar disorder, schizophrenia [110,112,113], and other psychiatric illnesses [105]. This evidence concerns the gene IL6 and depressive symptom measurement.